Procedural Characteristics and Outcomes of Transcatheter Interventions for Aortic Coarctation: A Report From the

Ada C Stefanescu Schmidt1, Aimee Armstrong2, Kevin F Kennedy3

  • 1Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts.

Insights

Transcatheter interventions for native coarctation of the aorta are safe and effective, especially stenting in older children and adults. Balloon angioplasty shows lower success rates and higher risks compared to stenting.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pediatric Cardiology

Background:

  • Coarctation of the aorta (CoA) traditionally treated with surgery.
  • Transcatheter interventions like balloon angioplasty (BA) and stenting are increasingly used for native CoA.
  • Largest multicenter registry data for congenital catheterization used to assess practice patterns and outcomes.

Purpose of the Study:

  • To determine practice patterns and acute outcomes of transcatheter interventions for native coarctation.
  • To compare procedural choice and outcomes between BA and stenting.
  • To analyze data from the IMPACT registry for native CoA interventions.

Main Methods:

  • Analysis of CoA interventions from the IMPACT National Cardiovascular Data Registry.
  • Comparison of procedure choice and acute outcomes in patients with native CoA.
  • Definition of procedural success (<20 mm Hg gradient) and optimal outcome (<10 mm Hg gradient), with no major adverse events (MAEs).

Main Results:

  • Over 8 years, 1187 native CoA procedures were analyzed; stenting was predominant in older children.
  • Procedural success was >90% for stenting versus 69% for BA.
  • Major adverse events (MAEs) were most frequent in infants (<1 year) and more common after BA than stenting.

Conclusions:

  • Transcatheter interventions for native coarctation are safe in older children and adults.
  • Stenting demonstrates a high degree of immediate procedural success.
  • Balloon angioplasty is associated with lower success rates and higher MAEs compared to stenting.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...